# AL-54478 Proof of Concept Study

> **NCT01318252** · PHASE2 · COMPLETED · sponsor: **Alcon Research** · enrollment: 64 (actual)

## Conditions studied

- Open-angle Glaucoma (OAG)
- Ocular Hypertension (OHT)

## Interventions

- **DRUG:** AL-54478 0.005%
- **DRUG:** Latanoprost 0.005%
- **DRUG:** AL-54478 Vehicle

## Key facts

- **NCT ID:** NCT01318252
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2014-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01318252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01318252, "AL-54478 Proof of Concept Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01318252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*